LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Cerrado

Sector Salud

68.56 0.63

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

68.38

Máximo

69.26

Métricas clave
By Trading Economics
Ingresos	14M 366M
Ventas	30M 1.6B
P/B Media del Sector	39.81 103.001
BPA	0.7
Margen de beneficio	22.472
Empleados	19,800
EBITDA	-59M 417M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+15.29 upside

Dividendos
By Dow Jones
Próximas Ganancias	23 oct 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-289M 42B
Apertura anterior	67.93
Cierre anterior	68.56

Noticias sobre sentimiento de mercado

By Acuity

38%

62%

74 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

68.24 / 69.92 Soporte y Resistencia

Edwards Lifesciences Corp Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 jul 2024, 13:57 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Buy Innovalve for $300 Million

3 sept 2024, 20:38 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 sept 2024, 20:37 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 sept 2024, 20:36 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 jul 2024, 09:02 UTC

Ganancias

Acciones populares

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 jul 2024, 08:40 UTC

Principales Noticias

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24 jul 2024, 20:17 UTC

Ganancias

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24 jul 2024, 20:15 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Sales $1.39B >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Net $366.3M >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q Adj EPS 70c >EW

24 jul 2024, 20:15 UTC

Ganancias

Edwards Lifesciences 2Q EPS 61c >EW

15 jul 2024, 13:42 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Buy Innovalve for $300M

15 jul 2024, 13:01 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15 jul 2024, 13:01 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15 jul 2024, 13:00 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15 jul 2024, 13:00 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences To Acquire Innovalve >EW

4 jun 2024, 17:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3 jun 2024, 13:26 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3 jun 2024, 12:25 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3 jun 2024, 11:03 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3 jun 2024, 10:40 UTC

Adquisiciones, fusiones, absorciones

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3 jun 2024, 10:32 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3 jun 2024, 10:31 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3 jun 2024, 10:30 UTC

Adquisiciones, fusiones, absorciones

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26 abr 2024, 20:10 UTC

Ganancias

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

25 abr 2024, 21:05 UTC

Ganancias

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

25 abr 2024, 20:32 UTC

Ganancias

Edwards Lifesciences Nabs Quarterly Beat And Plans A 'Critical' Spinoff -- IBD

Comparación entre iguales

Cambio de precio

Edwards Lifesciences Corp Esperado

Precio Objetivo

By TipRanks

15.29% repunte

Estimación a 12 meses

Media 79 USD 15.29%

Máximo 91 USD

Mínimo 70 USD

De acuerdo con 23 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Edwards Lifesciences Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

23 ratings

Comprar

Mantener

Vender

De acuerdo con 23 analistas que ofrecen calificaciones bursátiles a para Edwards Lifesciences Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

68.24 / 69.92Soporte y Resistencia

Bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentimiento

By Acuity

74 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

EBITDA

Beneficio operativo

Acerca de Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.